These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12020162)

  • 21. Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance.
    Krishna S; Woodrow CJ; Staines HM; Haynes RK; Mercereau-Puijalon O
    Trends Mol Med; 2006 May; 12(5):200-5. PubMed ID: 16616639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A quantum chemistry investigation on antimalarial mechanism of Qinghaosu based on cleavage of the peroxide bridge].
    Liang RL; Liu TW; Qu LB; Tang MS; Xiang BR
    Yao Xue Xue Bao; 2006 Jun; 41(6):544-7. PubMed ID: 16927830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why artemisinin and certain synthetic peroxides are potent antimalarials. Implications for the mode of action.
    Jefford CW
    Curr Med Chem; 2001 Dec; 8(15):1803-26. PubMed ID: 11772352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs.
    Robert A; Dechy-Cabaret O; Cazelles J; Meunier B
    Acc Chem Res; 2002 Mar; 35(3):167-74. PubMed ID: 11900520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of an antimalarial synthetic trioxolane drug development candidate.
    Vennerstrom JL; Arbe-Barnes S; Brun R; Charman SA; Chiu FC; Chollet J; Dong Y; Dorn A; Hunziker D; Matile H; McIntosh K; Padmanilayam M; Santo Tomas J; Scheurer C; Scorneaux B; Tang Y; Urwyler H; Wittlin S; Charman WN
    Nature; 2004 Aug; 430(7002):900-4. PubMed ID: 15318224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria.
    Svensson US; Alin H; Karlsson MO; Bergqvist Y; Ashton M
    Eur J Clin Pharmacol; 2002 Aug; 58(5):339-51. PubMed ID: 12185558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX.
    Delhaes L; Blot C; Berry L; Maciejewski LA; Camus D; Brocard JS; Dive D
    Bioorg Med Chem; 2000 Dec; 8(12):2739-45. PubMed ID: 11131165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemin-catalyzed decomposition of artemisinin (qinghaosu).
    Zhang F; Gosser DK; Meshnick SR
    Biochem Pharmacol; 1992 Apr; 43(8):1805-9. PubMed ID: 1575774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 3D quantitative structure-activity relationship methods: analysis of the in vitro antimalarial activity of 154 artemisinin analogues by hypothetical active-site lattice and comparative molecular field analysis.
    Woolfrey JR; Avery MA; Doweyko AM
    J Comput Aided Mol Des; 1998 Mar; 12(2):165-81. PubMed ID: 9690175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A medicinal chemistry perspective on artemisinin and related endoperoxides.
    O'Neill PM; Posner GH
    J Med Chem; 2004 Jun; 47(12):2945-64. PubMed ID: 15163175
    [No Abstract]   [Full Text] [Related]  

  • 31. Artemisinin, promising lead natural product for various drug developments.
    Lee S
    Mini Rev Med Chem; 2007 Apr; 7(4):411-22. PubMed ID: 17430226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of charge distribution on the antimalarial activity of artemisinin analogues.
    Rafiee MA; Hadipour NL; Naderi-manesh H
    J Chem Inf Model; 2005; 45(2):366-70. PubMed ID: 15807501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of the antimalarial drug precursor artemisinic acid in engineered yeast.
    Ro DK; Paradise EM; Ouellet M; Fisher KJ; Newman KL; Ndungu JM; Ho KA; Eachus RA; Ham TS; Kirby J; Chang MC; Withers ST; Shiba Y; Sarpong R; Keasling JD
    Nature; 2006 Apr; 440(7086):940-3. PubMed ID: 16612385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DFT study of the reductive decomposition of artemisinin.
    Taranto AG; de Mesquita Carneiro JW; de Araujo MT
    Bioorg Med Chem; 2006 Mar; 14(5):1546-57. PubMed ID: 16266806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progress in the research of artemisinin and its analogues as antimalarials: an update.
    Sriram D; Rao VS; Chandrasekhara KV; Yogeeswari P
    Nat Prod Res; 2004 Dec; 18(6):503-27. PubMed ID: 15595609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism-based design of parasite-targeted artemisinin derivatives: synthesis and antimalarial activity of benzylamino and alkylamino ether analogues of artemisinin.
    O'Neill PM; Bishop LP; Storr RC; Hawley SR; Maggs JL; Ward SA; Park BK
    J Med Chem; 1996 Oct; 39(22):4511-4. PubMed ID: 8893847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alkylation of human hemoglobin A0 by the antimalarial drug artemisinin.
    Selmeczi K; Robert A; Claparols C; Meunier B
    FEBS Lett; 2004 Jan; 556(1-3):245-8. PubMed ID: 14706857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heme-dependent radical generation from antimalarial fungal metabolites, radicicol and heptelidic acid.
    Tanaka Y; Fang F; Zhang CH; Zhang XW; Omura S
    J Antibiot (Tokyo); 1998 Apr; 51(4):451-3. PubMed ID: 9630871
    [No Abstract]   [Full Text] [Related]  

  • 39. Artemisinin and chloroquine: do mode of action and mechanism of resistance involve the same protagonists?
    Lelièvre J; Berry A; Benoit-Vical F
    Curr Opin Investig Drugs; 2007 Feb; 8(2):117-24. PubMed ID: 17328227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of the potent anti-malarial drug artemisinin in tobacco.
    Farhi M; Marhevka E; Ben-Ari J; Algamas-Dimantov A; Liang Z; Zeevi V; Edelbaum O; Spitzer-Rimon B; Abeliovich H; Schwartz B; Tzfira T; Vainstein A
    Nat Biotechnol; 2011 Dec; 29(12):1072-4. PubMed ID: 22158354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.